Alzheimer's Amyloid Precursor Protein α-Secretase Is Inhibited by Hydroxamic Acid-Based Zinc Metalloprotease Inhibitors: Similarities to the Angiotensin Converting Enzyme Secretase
- 22 January 1998
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 37 (6) , 1680-1685
- https://doi.org/10.1021/bi972034y
Abstract
The 4 kDa β-amyloid peptide that forms the amyloid fibrils in the brain parenchyma of Alzheimer's disease patients is derived from the larger integral membrane protein, the amyloid precursor protein. In the nonamyloidogenic pathway, α-secretase cleaves the amyloid precursor protein within the β-amyloid domain, releasing an extracellular portion and thereby preventing deposition of the intact amyloidogenic peptide. The release of the amyloid precursor protein from both SH-SY5Y and IMR-32 neuronal cells by α-secretase was blocked by batimastat and other related synthetic hydroxamic acid-based zinc metalloprotease inhibitors, but not by the structurally unrelated zinc metalloprotease inhibitors enalaprilat and phosphoramidon. Batimastat inhibited the release of the amyloid precursor protein from both cell lines with an I50 value of 3 μM. Removal of the thienothiomethyl substituent adjacent to the hydroxamic acid moiety or the substitution of the P2‘ substituent decreased the inhibitory potency of batimastat toward α-secretase. In the SH-SY5Y cells, both the basal and the carbachol-stimulated release of the amyloid precursor protein were blocked by batimastat. In contrast, neither the level of full-length amyloid precursor protein nor its cleavage by β-secretase were inhibited by any of the zinc metalloprotease inhibitors examined. In transfected IMR-32 cells, the release of both the amyloid precursor protein and angiotensin converting enzyme was inhibited by batimastat, marimastat, and BB2116 with I50 values in the low micromolar range, while batimastat and BB2116 inhibited the release of both proteins from HUVECs. The profile of inhibition of α-secretase by batimastat and structurally related compounds is identical with that observed with the angiotensin converting enzyme secretase suggesting that the two are closely related zinc metalloproteases.Keywords
This publication has 20 references indexed in Scilit:
- Families of zinc metalloproteasesPublished by Wiley ,2001
- A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cellsNature, 1997
- Amyloid β-Protein and the Genetics of Alzheimer's DiseaseJournal of Biological Chemistry, 1996
- Diverse Cell Surface Protein Ectodomains Are Shed by a System Sensitive to Metalloprotease InhibitorsPublished by Elsevier ,1996
- Gelatinase A possesses a β‐secretase‐like activity in cleaving the amyloid protein precursor of Alzheimer's diseaseFEBS Letters, 1995
- Processing of the β‐Amyloid Precursor Protein and Its Regulation in Alzheimer's DiseaseJournal of Neurochemistry, 1995
- Amyloid precursor protein secretion and βA4 amyloid generation are not mutually exclusiveFEBS Letters, 1994
- Gelatinase A not alpha-secretase?Nature, 1994
- Measurement of protein using bicinchoninic acidAnalytical Biochemistry, 1985
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983